Atea Pharmaceuticals, Inc. 10-K filing
Filed 2026-03-05 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001193125-26-094159
- Form type
- 10-K
- CIK
- 0001593899
- Primary document
- https://www.sec.gov/Archives/edgar/data/1593899/000119312526094159/avir-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Atea Pharmaceuticals, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-180.9M | - | - |
| Net Income | $-158.3M | - | - |
| Eps Basic | -1.94 | - | - |
| Eps Diluted | -1.94 | - | - |
| Cash And Equivalents | $95.7M | - | - |
| Total Assets | $315.2M | - | - |
| Total Liabilities | $39.8M | - | - |
| Shareholders Equity | $275.4M | - | - |
| Operating Cash Flow | $-132.0M | - | - |